[ad_1] NAPERVILLE, Illinois, 30 septembre 2024 /PRNewswire/ — Endotronix, une société d’Edwards Lifesciences (NYSE : EW), annonce aujourd’hui les résultats cliniques à un an de PROACTIVE-HF, qui évalue les résultats du système de capteur Cordella […]

[ad_1] NAPERVILLE, Ill., Sept. 28, 2024 /PRNewswire/ — Endotronix, an Edwards Lifesciences company (NYSE: EW), today announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes for the Cordella Pulmonary Artery (PA) Sensor System. The data […]

[ad_1] NAPERVILLE, Ill., Sept. 28, 2024 /PRNewswire/ — Endotronix, an Edwards Lifesciences company (NYSE: EW), today announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes for the Cordella Pulmonary Artery (PA) Sensor System. The data […]